Efficacy and toxicity of gemcitabine/ dexamethasone / carboplatin versus ESHAP protocol in treatment of relapsed/ refractory Non-Hodgkin’s lymphomas (NHL)

Efficacy and toxicity of gemcitabine/ dexamethasone / carboplatin versus ESHAP protocol in treatment of relapsed/ refractory Non-Hodgkin’s lymphomas (NHL)

Sensitivitytosalvage chemotherapy is one of the strongest predictors of OS and PFS after high-dose therapy with autologous bone marrow or peripheral blood stem cell transplantation (ABMT) in relapsed or refractory non-Hodgkin’slymphoma. Consequently, efforts have been  focused  on developing salvage...

Full description

Bibliographic Details
Main Authors: Fatma Abbas, Mohamed Abd El kader, Mohamed M.El-wakil, Ahmad Shaban
Format: Article
Language:English
Published: Beni-Suef University, Faculty of Medicine 2022-04-01
Series:Egyptian Journal of Medical Research
Subjects:
relapsed or refractory nhl
salvage chemotherapy regimens
high-dose therapy with autologous stem cell transplantation (asct)
gem /dexa/carbo
eshap
response rate and toxicity
Online Access:https://ejmr.journals.ekb.eg/article_238694_adb4ea0d47c703079b72ac4fcb8a2649.pdf

Internet

https://ejmr.journals.ekb.eg/article_238694_adb4ea0d47c703079b72ac4fcb8a2649.pdf

Similar Items